North India's Leading Hormone Specialist — Full-Spectrum Hormonal Care in Mohali & Chandigarh
Hormones govern energy, metabolism, fertility, bone density, cognition, and how you age. At Gini Advanced Care Hospital, Dr. Anil Bhansali — Asia's top-rated endocrinologist with 45 years of clinical experience and 700+ research papers — offers the most precise, evidence-based hormonal medicine available in North India.
of metabolic patients achieve HbA1c <7.0 in 12 weeks
700+
peer-reviewed research publications
45 yrs
dedicated clinical endocrinology experience
50,000+
patients treated across North India
Your Specialist
Meet Dr. Anil Bhansali
Director & Senior Endocrinologist — the doctor other doctors refer to when hormones are complex.
Dr. Anil Bhansali
MBBS · MD · DM (Endocrinology), PGIMER Chandigarh
Director & Senior Endocrinologist, Gini Advanced Care Hospital · Asia's Top-Rated Endocrinologist
Dr. Anil Bhansali is one of the most decorated endocrinologists in Asia. He completed his DM in Endocrinology from PGIMER, Chandigarh — India's premier postgraduate medical institution — and served as Head of the Department of Endocrinology there for many years. With 45 years of clinical practice and over 700 peer-reviewed research publications spanning diabetes, thyroid disease, pituitary disorders, adrenal diseases, male and female hormonal health, and endocrine oncology, he has trained generations of Indian endocrinologists. His research has directly shaped clinical guidelines followed across South Asia.
Dr. Bhansali's approach to hormonal health is context-first: the same TSH value in a 40-year-old and an 82-year-old represents entirely different clinical realities. He integrates cutting-edge longevity science — including the insulin/IGF-1 axis, somatopause, sex hormone timing windows, and India-specific metabolic phenotypes — with 45 years of patient-facing experience. For patients who have spent years being told their levels are "normal," Dr. Bhansali's comprehensive evaluation often delivers the answers they were looking for.
PGIMER ChandigarhDM EndocrinologyFormer HOD, PGIMER700+ PublicationsAsia Top-Rated45 Years Experience50,000+ Patients
Dual-Specialist Oversight for TRT — Dr. Bhansali + Dr. Aggarwal
Testosterone Replacement Therapy at Gini Hospital is co-managed by Dr. Bhansali (endocrine & metabolic oversight) and Dr. Nitin Aggarwal (urological & andrological assessment). This dual-specialist model ensures complete evaluation — including prostate health, haematocrit monitoring, sperm production, and cardiovascular parameters — before and throughout TRT. It is the safest and most thorough way to manage testosterone therapy. Learn about Urology & Andrology →
What We Treat
Six Hormonal Conditions. One Expert Centre.
Dr. Bhansali's practice spans the complete hormonal spectrum — from testosterone and menopause to insulin resistance, thyroid, PCOS, and growth hormone. These conditions do not exist in isolation; expert management connects them.
Testosterone declines approximately 1% per year after age 40. Simultaneously, sex hormone binding globulin (SHBG) rises — reducing biologically active free testosterone further. The result is late-onset hypogonadism, or andropause. In India, premature andropause is significantly more common in men with metabolic syndrome and chronic occupational stress. Screening testosterone levels in men aged 45 and above with Type 2 diabetes and persistent fatigue is clinically justified and dramatically underutilised.
Confirmed Hypogonadism Threshold:
Testosterone <300 ng/dL plus characteristic symptoms — both criteria must be present for diagnosis. A single low value without symptoms, or symptoms without a confirmed low level, does not constitute hypogonadism.
Symptoms of Testosterone Deficiency:
Fatigue & low energy — persistent, not explained by sleep or workload
Reduced libido — loss of sexual desire and drive
Erectile dysfunction — difficulty achieving or maintaining erection
Muscle loss & fat gain — especially visceral abdominal fat
Cognitive fog — reduced concentration, memory, processing speed
Bone density loss — increased osteoporosis risk with prolonged deficiency
Evidence for TRT:
✔ Sexual function✔ Energy & mood✔ Muscle mass✔ Bone density
🇮🇳
India Context
Metabolic syndrome prevalence, chronic psychosocial stress, and near-universal Vitamin D deficiency accelerate andropause in Indian men. Routine testosterone screening in men ≥45 with T2DM and fatigue is strongly warranted but rarely performed. See Andropause Treatment →
Menopausal Hormone Therapy · Perimenopause · Early Menopause
The ovary is the first tissue to age in the female body — measurable decline begins from age 37. Estradiol (E2) loss triggers a cascade across every major organ system. In the first five years of menopause, bone loss accelerates at 3–5% per year. Cardiovascular disease risk rises significantly. Women who reach menopause before age 45 (early menopause) carry a 27% higher risk of metabolic syndrome compared to those reaching it at the expected age. Cognitive changes, genitourinary syndrome (vaginal dryness, recurrent UTIs, urinary urgency), and mood disruption are not inevitable — they are treatable.
The Timing Window — When MHT Works Best:
Started before age 60 OR within 10 years of menopause onset → benefits outweigh risks for bone protection, cardiovascular health, and vasomotor symptom relief (NICE 2024). Starting MHT after age 65 is generally not recommended.
Hot flushes & night sweats — vasomotor symptoms, often the most disabling
Bone density protection — E2 maintains osteoblast activity and slows resorption
Cardiovascular risk reduction — within the timing window
Genitourinary syndrome — local E2 restores vaginal mucosa and reduces recurrent UTIs
Cognitive & mood effects — emerging evidence for cognitive protection
PCOS is fundamentally an endocrine and metabolic disorder, not simply a gynaecological one. Insulin resistance sits at its root — driving hyperinsulinaemia that stimulates the ovaries to overproduce androgens, disrupting the normal LH/FSH ratio and preventing regular ovulation. The downstream consequences reach far beyond irregular cycles: acne, hirsutism (excess facial/body hair), alopecia, difficulty conceiving, and a significantly elevated lifetime risk of Type 2 diabetes, metabolic syndrome, and cardiovascular disease. PCOS requires a combined hormonal and metabolic management approach — not a one-dimensional solution.
Long-term risks — T2DM, cardiovascular disease, endometrial cancer risk
Psychological impact — body image, anxiety, depression often unaddressed
⚠️
India Carries the Highest Organochlorine Burden Globally
Endocrine-disrupting chemicals — organochlorine pesticides from agricultural exposure, plasticisers (BPA, phthalates) from food packaging — directly worsen PCOS by mimicking and disrupting hormonal signalling. India has the highest measured organochlorine pesticide burden globally. Comprehensive PCOS care at Gini Hospital addresses this environmental context.
Thyroid disease is among the most common endocrine conditions in India, affecting an estimated 42 million Indians. Subclinical hypothyroidism (mildly elevated TSH with normal thyroid hormones) increases significantly with age. But here is where context matters enormously — and where specialist care diverges from routine: a TSH of 5.5 in a 38-year-old with fatigue and weight gain is a very different clinical problem from a TSH of 5.5 in an 82-year-old. The 82-year-old may not need treatment; the 38-year-old likely does. Overtreating thyroid function — a common error — carries real consequences: excess T4 drives atrial fibrillation and accelerates bone loss. Undertreating causes metabolic slow-down, cognitive fog, and cardiovascular risk.
Thyroid nodules — majority benign; evaluation with ultrasound + FNAC where indicated
Postpartum thyroiditis — often missed; presents as post-delivery fatigue and mood disturbance
Thyroid and pregnancy — TSH targets differ in pregnancy; requires close monitoring throughout
Dr. Bhansali's approach: Treat the patient, not the number. TSH, fT3, and fT4 are interpreted alongside clinical symptoms, age, cardiovascular risk, and bone density. Over-reliance on TSH alone results in both over-treatment and under-treatment.
🔋
Insulin Resistance & IGF-1 Axis
The Most Important Longevity Axis · Metabolic Hormonal Health
The insulin/IGF-1 axis is the most important longevity-regulating hormonal axis in the body. Lower insulin levels and lower IGF-1 signalling are consistently associated with longer healthspan across every model organism studied — including humans. Centenarians, as a group, have lower IGF-1 and better insulin sensitivity than average-aged adults. The inverse — hyperinsulinaemia — accelerates cellular senescence (biological ageing), promotes vascular and endothelial damage, drives inflammatory signalling, and creates a hormonal environment hostile to longevity. Treating insulin resistance is, at its core, hormonal medicine and longevity medicine simultaneously.
How Insulin Resistance Damages Hormonal Health:
Suppresses SHBG — raises free androgens in women (PCOS), reduces effective testosterone in men
Promotes visceral fat — adipose tissue converts testosterone to estrogen via aromatase
Vascular damage — endothelial dysfunction reduces blood flow to gonads, impairing hormonal production
Clinical implication: Achieving metabolic control — normal fasting insulin, HOMA-IR <1.5, HbA1c <5.7% — is not just diabetes management. It is hormonal health. It is longevity medicine. It is the single most impactful intervention available in modern endocrinology. See Diabetes Treatment →
📈
Growth Hormone & Somatopause
Adult GH Deficiency · Somatopause · IGF-1 · Body Composition
Growth hormone (GH) production declines approximately 14% per decade from age 30 onwards — a process called somatopause. This gradual loss contributes to increasing visceral fat accumulation, declining lean muscle mass and bone density, impaired physical recovery, reduced exercise capacity, and cognitive fog. Importantly, GH replacement therapy is only indicated for confirmed Adult Growth Hormone Deficiency (AGHD) — a distinct medical condition diagnosed by stimulation testing — and is emphatically not an anti-ageing or wellness treatment. Dr. Bhansali is one of the few clinicians in North India with the diagnostic and management expertise for AGHD.
Visceral fat increase — GH decline shifts body composition toward central obesity
Lean muscle & bone loss — GH is anabolic; deficiency accelerates sarcopenia and osteopenia
Impaired recovery — physical and cognitive recovery from exertion or illness is blunted
Cognitive fog — GH receptors are present throughout the brain; deficiency affects cognition
Cardiovascular profile — AGHD is independently associated with increased CV risk
Important: GH therapy is reserved for confirmed AGHD (biochemically proven by stimulation testing). Dr. Bhansali does not prescribe GH for non-medical indications. If another provider has offered you GH therapy without a formal stimulation test, this should raise serious concern.
Why Indian Patients Are at Higher Hormonal Risk
Four systemic factors make hormonal health uniquely challenging in India — and they require an India-aware specialist.
Sarcopenic Obesity — The 'Thin-Fat' Phenotype
Indians have disproportionately high body fat relative to BMI — especially visceral fat — compared to Western populations at the same weight. This 'thin-fat' phenotype drives higher insulin resistance, earlier testosterone decline in men, and more severe PCOS outcomes in women at lower body weights than expected. Standard Western BMI thresholds miss this population entirely.
Near-Universal Vitamin D Deficiency
Despite abundant sunlight, India has exceptionally high rates of Vitamin D deficiency — estimated at 70–90% of the population. Vitamin D is a pro-hormone: it regulates testosterone biosynthesis, insulin signalling, thyroid receptor function, and immune-endocrine crosstalk. Correcting Vitamin D deficiency alone frequently improves testosterone levels, insulin sensitivity, and thyroid function in subclinically deficient patients.
Highest Organochlorine Pesticide Burden Globally
India carries the world's highest measured burden of organochlorine pesticide residues — in soil, food, water, and human adipose tissue. These persistent endocrine-disrupting chemicals mimic and block hormonal signalling, worsening PCOS, suppressing testosterone, disrupting thyroid function, and impairing fertility. No validated Indian hormone reference ranges exist for a population with this exposure profile.
No Validated Indian Hormone Reference Ranges
Hormone reference ranges used across Indian labs and clinics are derived from Western populations — typically North American or European cohorts. Given the documented differences in body composition, Vitamin D status, pesticide burden, genetic polymorphisms, and metabolic phenotype, these ranges may be systematically incorrect for Indian patients. Dr. Bhansali interprets results with this context explicitly in mind.
Our Philosophy
Healthspan, Not Just Lifespan
Dr. Bhansali's philosophy, drawn from his landmark presentation "Hormones and Longevity": the goal of hormonal medicine is not to recreate the hormonal profile of a 25-year-old. It is to preserve function, strength, cognition, and independence for as long as possible.
🎯
Treat the Patient, Not the Number
Hormone levels are one data point among many. A testosterone of 290 ng/dL in a symptomatic 45-year-old with metabolic syndrome is a different problem from the same value in an asymptomatic 70-year-old. A TSH of 5 in an 82-year-old is not the same clinical problem as a TSH of 5 in a 40-year-old. Context, symptoms, co-morbidities, and goals determine treatment — not thresholds alone.
⏱️
Timing Windows Matter Enormously
MHT started within 10 years of menopause onset or before age 60 confers cardiovascular, bone, and cognitive benefits. The same therapy started after 65 does not. TRT in confirmed hypogonadism reverses metabolic changes when started before muscle and bone loss become irreversible. The endocrine system has critical windows — and missing them has permanent consequences.
🔗
Hormones Are Interconnected Systems
Insulin resistance worsens testosterone deficiency. Testosterone deficiency worsens insulin resistance. Low Vitamin D impairs thyroid function and testosterone synthesis. Cortisol excess suppresses all anabolic hormones. Treating each hormone in isolation misses the network. Dr. Bhansali's comprehensive endocrine assessment maps the full axis and intervenes at the most effective leverage points.
Foundation
Lifestyle IS Hormone Medicine
Before prescribing any therapy, Dr. Bhansali addresses the six lifestyle levers that directly regulate the hormonal axis. These are not "nice to have" additions — they are mechanistically evidence-based interventions with measurable hormonal effects.
🏋️
Resistance Training
Directly increases testosterone and GH, stimulates local IGF-1 in muscle, maintains insulin sensitivity, and builds the lean mass reserve that protects against somatopause and andropause.
🚴
Zone 2 Aerobic Exercise
Low-intensity steady-state cardio (conversational pace, 30–45 min, 4–5x/week) is the most effective intervention for improving mitochondrial function and insulin sensitivity without the cortisol burden of high-intensity training.
😴
Sleep Optimisation
80% of daily growth hormone secretion occurs during deep sleep. Testosterone peaks in the early morning hours of quality sleep. Even one night of sleep deprivation reduces testosterone by 10–15%. Sleep is not passive — it is the hormonal repair cycle.
🍽️
Caloric Restriction & TRE
Time-Restricted Eating (TRE) and moderate caloric restriction reduce insulin and IGF-1 signalling — the two longevity-regulating axes. This is among the most reproducible pro-longevity interventions in human studies.
🧘
Stress Management
Chronic cortisol elevation — from work, relationship, or financial stress — suppresses testosterone, growth hormone, and thyroid function simultaneously. Cortisol is catabolic; it dismantles the hormonal architecture that lifestyle builds. Stress reduction is endocrine medicine.
☀️
Vitamin D Optimisation
Vitamin D deficiency — present in 70–90% of Indians — impairs testosterone biosynthesis, worsens insulin resistance, and reduces thyroid receptor sensitivity. Achieving 25-OH-D levels of 50–80 ng/mL is a foundational step before any hormonal pharmacotherapy.
Your Journey at Gini
How a Hormonal Health Assessment Works
From first appointment to ongoing monitoring — a clear, structured process built around getting the diagnosis right.
Step
What Happens
Who Leads
Outcome
1. Initial Consultation
Detailed history: symptoms, timeline, previous test results, medications, lifestyle, family history. Assessment for all six hormonal axes.
In-person (preferred for initial) Online / Video available Telephonic for follow-up
What to Bring
All previous blood reports Current medication list Symptom history (even if dismissed)
Frequently Asked Questions
Hormonal Health — Your Questions Answered
Clinical answers to the questions Dr. Bhansali hears most often in his consultation room.
How do I know if I have a hormonal imbalance?
Symptoms vary by hormone affected, but common signs include unexplained fatigue, weight gain (especially around the abdomen), low libido, mood swings, poor sleep, brain fog, hair thinning, irregular periods, and muscle weakness. A proper hormonal assessment by an endocrinologist includes targeted blood tests — testosterone, FSH, LH, estradiol, thyroid panel (TSH, fT3, fT4), fasting insulin, HOMA-IR, and IGF-1 — interpreted in the context of your age, sex, symptoms, and metabolic status. Numbers alone do not make a diagnosis; clinical context does. Many patients have spent years being told their results are "normal" — often because the wrong tests were ordered, or the right tests were misinterpreted.
Is Testosterone Replacement Therapy (TRT) safe? What are the risks?
TRT is safe and evidence-based when prescribed for confirmed hypogonadism — testosterone below 300 ng/dL with matching clinical symptoms. Evidence clearly supports benefits to sexual function, energy, mood, muscle mass, and bone density. Real risks include haematocrit elevation (thickening of blood), potential cardiovascular effects at supraphysiologic doses, suppression of natural testosterone production, and impact on sperm production (important for men planning future fertility). These risks are manageable with appropriate monitoring and the correct delivery method. At Gini Hospital, TRT is co-managed by Dr. Bhansali (endocrine oversight) and Dr. Nitin Aggarwal (urological and andrological monitoring) — ensuring comprehensive pre-therapy evaluation and ongoing safety surveillance. TRT should never be started without both biochemical and clinical diagnosis confirmed by a specialist.
Should I take Menopausal Hormone Therapy (MHT)? I'm worried about breast cancer.
The breast cancer concern around MHT originates from a 2002 WHI (Women's Health Initiative) study whose findings have since been substantially revised. The study used oral conjugated equine estrogen plus medroxyprogesterone in older, mostly post-menopausal women — not the formulations or timing used today. For healthy women under 60, or within 10 years of menopause onset — the "critical timing window" — current NICE 2024 and British Menopause Society guidance indicates that the benefits of MHT (bone protection, cardiovascular health, vasomotor symptom relief, genitourinary health, quality of life) outweigh the risks for most women. Women reaching early menopause (before age 45) carry a higher absolute risk from NOT taking MHT than from taking it. Breast cancer risk with modern MHT is small, context-dependent, and must be weighed against the very real risks of untreated estrogen deficiency. Dr. Bhansali individualises every MHT decision based on your complete medical history.
Can PCOS be cured, or only managed?
PCOS is a lifelong endocrine condition — it cannot be eliminated in the conventional sense of a cure. However, with targeted treatment addressing its root drivers (primarily insulin resistance and androgen excess), the majority of women achieve significant improvement in cycle regularity, skin/hair changes, fertility, and metabolic risk. Many women with PCOS find their symptoms improve substantially after menopause, when the hormonal drivers shift. The goal at Gini Hospital is not to simply manage symptoms with pills, but to address the underlying metabolic and hormonal dysfunction — through insulin-sensitising therapy, lifestyle modification, hormonal regulation, and monitoring for long-term risks including Type 2 diabetes and cardiovascular disease. PCOS is a lifelong condition that requires a lifelong specialist relationship.
What blood tests do I need for a complete hormone assessment?
A thorough hormonal workup at Gini Hospital typically covers: Gonadal axis: Testosterone (total and free), SHBG, LH, FSH, estradiol (women). Thyroid: TSH, free T3, free T4, anti-TPO antibodies. Metabolic axis: Fasting insulin, HOMA-IR, HbA1c, fasting glucose, lipid profile. Longevity markers: IGF-1 (GH axis proxy), 25-OH Vitamin D. Additional where indicated: DHEA-S, cortisol (AM), prolactin, GH stimulation testing, pituitary imaging. Not all patients need all tests — Dr. Bhansali tailors the panel based on your specific symptom profile and previous results.
What is the difference between a general physician and an endocrinologist for hormonal issues?
A general physician can screen for obvious hormonal problems and manage straightforward thyroid replacement. An endocrinologist holds 3–6 additional years of subspecialty training in hormonal medicine — covering the full interplay of insulin, sex hormones, thyroid, adrenal hormones, growth hormone, pituitary function, and their systemic effects. Dr. Bhansali has 45 years of this specialist experience and 700+ peer-reviewed publications. For complex, persistent, or multi-hormonal problems — testosterone deficiency, PCOS, subclinical thyroid disease, insulin resistance, adult GH deficiency — the depth of knowledge an endocrinologist brings directly changes outcomes. Getting the diagnosis and treatment right the first time saves years of mismanagement and its consequences.
What is the difference between andropause and erectile dysfunction?
Andropause (late-onset hypogonadism) is a hormonal syndrome characterised by the gradual decline of testosterone with age. Its symptoms are systemic: fatigue, low libido, mood and cognitive changes, muscle loss, bone density reduction, and metabolic shifts. Erectile dysfunction (ED) is specifically the inability to achieve or maintain an adequate erection. These two conditions frequently co-exist and overlap — low testosterone contributes to ED in many men — but they are not identical. A man can have significant andropause without severe ED, or severe ED (from vascular or neurological causes) with normal testosterone. Correct diagnosis requires both endocrine evaluation (Dr. Bhansali) and urological/andrological assessment (Dr. Aggarwal). Treating ED without addressing underlying testosterone deficiency, if present, often yields poor long-term results. Read more about Andropause →
How does insulin resistance affect hormones?
Insulin resistance is simultaneously a metabolic and hormonal disorder. Chronically elevated insulin (hyperinsulinaemia) suppresses sex hormone binding globulin (SHBG) — this raises free androgens in women (directly worsening PCOS) while paradoxically reducing bioavailable testosterone in men. Visceral fat accumulation driven by insulin resistance activates aromatase, which converts testosterone to estrogen in men — further reducing testosterone. Hyperinsulinaemia suppresses the nocturnal growth hormone pulse, impairs IGF-1 regulation, and accelerates cellular ageing through chronic pro-growth signalling. It is the central hormonal disruption in the Indian thin-fat sarcopenic phenotype. This is why Dr. Bhansali treats insulin resistance as hormonal medicine — and why patients achieving metabolic control frequently see improvements across multiple hormonal axes simultaneously. See Diabetes & Metabolic Treatment →
Related at Gini
Connected Programmes & Specialties
Hormonal health connects deeply to our other clinical programmes. These are the most clinically relevant links for patients at Gini Hospital.
Whether it's persistent fatigue, testosterone concerns, menopause, PCOS, a thyroid question, or a metabolic deep-dive — Dr. Bhansali's consultation is where you get answers grounded in 45 years of clinical expertise and 700 research papers.
